Late life intervention to improve function in elderly patients with depression

Conditions

None listed

Kerse N, Falloon K, Moyes SA, Hayman KJ, Dowell T, Kolt GS, Elley CR, Hatcher S, Peri K, Keeling S, Robinson E, Parsons J, Wiles J, Arroll B.

2008-05-2415 citations

10.1186/1471-2318-8-12

Papers published before 2003-12-01 may not appear yet. Historical indexing is in progress.

Interventions

A trained research nurse conducts a functional assessment Participant identifies a functional goal (with the assistance of the COPM) Research nurse designs an individualised home-based physical activity programme based on attaining the functional goal The intervention will be an adaptation of the Otago Exercise Programme - regular walking, three times weekly, progressive resistance training of lower leg strengthening using weights, and balance retraining using progressive balance exercises â¿¿

A trained research nurse conducts a functional assessment Participant identifies a functional goal (with the assistance of the COPM) Research nurse designs an individualised home-based physical activity programme based on attaining the functional goal The intervention will be an adaptation of the Otago Exercise Programme - regular walking, three times weekly, progressive resistance training of lower leg strengthening using weights, and balance retraining using progressive balance exercises â¿¿ with the addition of arm strengthening exercises and tai chi exercises for balance. Social contact will be encouraged by involvement of an exercise and walking companion. The intervention nurse will visit on weeks 0, 1, 2, 4, 5, 8, and 12 (3 months) to ensure adherence and progression of activity. Participants will be encouraged to maintain the programme independently up to a total of 12 months.

Study design

Allocation

Randomised controlled trial

Intervention model

Single group

Primary purpose

Prevention

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

75 Years to No maximum

Healthy volunteers

No

Inclusion criteria

Eligible patients include those able to communicate in English, and screened as suffering from depression. Patients who are already on pharmacotherapy for depression will be eligible to participate in the trial.

Exclusion criteria

Patients will be excluded if they suffer from dementia, terminal illness or an unstable cardiac condition, are unable to communicate in English, or are not living in Auckland permanently.

Outcome results